ReviewCurrent gastroenterology reports2007
Post-infectious irritable bowel syndrome.
Review in Current gastroenterology reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 33 citations in OpenAlex.
- Cow's Milk Protein Allergy in Infancy: A Risk Factor for Functional Gastrointestinal Disorders in Children?Nutrients · 2018Review
- Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS‑induced colitis.Molecular medicine reports · 2018Article
- Brain and gut interactions in irritable bowel syndrome: new paradigms and new understandings.Current gastroenterology reports · 2014Review
- Tropical sprue in 2014: the new face of an old disease.Current gastroenterology reports · 2014Review
- GeoSentinel surveillance of illness in returned travelers, 2007-2011.Annals of internal medicine · 2013Article
- Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas.Gastroenterology & hepatology · 2013Article
- Luminal hypertonicity and acidity modulate colorectal afferents and induce persistent visceral hypersensitivity.American journal of physiology. Gastrointestinal and liver physiology · 2012Article
- Soluble mediators released from PI-IBS patients' colon induced alteration of mast cell: involvement of reactive oxygen species.Digestive diseases and sciences · 2012Article
- New insights into visceral hypersensitivity--clinical implications in IBS.Nature reviews. Gastroenterology & hepatology · 2011Review
- MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.Gut · 2010Article
- Travel and travelers' diarrhea in patients with irritable bowel syndrome.The American journal of tropical medicine and hygiene · 2010Article
- Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.Brain, behavior, and immunity · 2010Review
- Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.BMC gastroenterology · 2009Article
- Irritable bowel syndrome and inflammatory bowel disease: infectious gastroenteritis-related disorders?Clinical journal of gastroenterology · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irritable bowel syndrome (IBS) is a common disorder associated with abdominal pain or discomfort and altered bowel habits. The majority of patients describe an insidious onset of symptoms; however, a subset report a fairly precise time of onset following an attack of acute gastroenteritis. Typically, the potential acute infectious symptoms, such as fever and vomiting, resolve after several days, but abdominal discomfort, bloating, and diarrhea persist. Although the underlying mechanism of post-infectious IBS (PI-IBS) has not been established, ongoing inflammation appears to play a role, with an increase in serotonin-containing enterochromaffin cells, T lymphocytes, mast cells, proinflammatory cytokines, and intestinal permeability. Psychiatric comorbidities are less common in PI-IBS, compared with IBS patients in general; however, the prevalence of psychological disorders is still higher compared with that in the general population and is associated with a poorer prognosis. Overall, patients with PI-IBS have a slightly improved prognosis compared with those with IBS without an infectious onset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.